Home › NDC Lookup › RxCUI directory › RxCUI 238013

Oxytocin 10 UNT/ML Injectable Solution — RxCUI 238013

RxNorm drug concept · Semantic clinical drug
RxCUI 238013 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI238013
Official nameOxytocin 10 UNT/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped8
Package NDCs mapped12
Reported Medicaid activity (SDUD)1,478 prescriptions · 13 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Oxytocin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It makes the uterus contract. It's used to start or strengthen labor when there's a medical reason, to help manage incomplete or inevitable abortion, and to control bleeding after...
  • A healthcare professional gives it in a hospital. To start or strengthen labor, it goes through an IV drip with a pump and close monitoring. After delivery, it may be given by IV o...
  • Nausea and vomiting are possible. Heart rhythm changes and spikes in blood pressure have also been reported. Your team watches your contractions and your baby's heart rate closely.
  • Yes. Overly strong contractions can lead to uterine rupture, bleeding, and harm to the baby. Water intoxication and severe allergic reactions can also happen. If contractions get t...
📖 Read our full Oxytocin Injection guide →

🕸️ Concept Web — How Oxytocin 10 UNT/ML Injectable Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Oxytocin 10 UNT/ML Injectable Solution RxCUI 238013

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Oxytocin 7824
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Pitocin 227199
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Oxytocin Injectable Solution 93672
    • Oxytocin Injectable Product 1162896
    • Oxytocin Injectable Solution [Pitocin] 93786
    • Pitocin Injectable Product 1181258
    • Injectable Solution 316949
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Oxytocin 10 UNT/ML SCDC · 316427
  • Oxytocin Injectable Solution SCDF · 93672
  • Oxytocin Injectable Product SCDG · 1162896

Brand-Name Concepts

📦 FDA Products & Package NDCs

8 products · 12 package NDCs
12 package NDCs map to RxCUI 238013 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9742-25 25 VIAL in 1 CARTON (0143-9742-25) / 10 mL in 1 VIAL (0143-... Oxytocin West-Ward Pharmaceuticals Corp 2013-02-13
00143-9743-25 25 VIAL in 1 CARTON (0143-9743-25) / 1 mL in 1 VIAL (0143-9... Oxytocin West-Ward Pharmaceuticals Corp 2013-02-13
42023-0116-02 25 VIAL in 1 CARTON (42023-116-02) / 10 mL in 1 VIAL Pitocin Par Health USA, LLC 2008-02-01
42023-0116-25 25 VIAL in 1 TRAY (42023-116-25) / 1 mL in 1 VIAL Pitocin Par Health USA, LLC 2008-02-01
42023-0116-73 25 VIAL in 1 CARTON (42023-116-73) / 10 mL in 1 VIAL Pitocin Par Health USA, LLC 2023-12-22
42023-0116-83 25 VIAL in 1 CARTON (42023-116-83) / 1 mL in 1 VIAL Pitocin Par Health USA, LLC 2023-12-22
42023-0116-93 25 VIAL in 1 CARTON (42023-116-93) / 10 mL in 1 VIAL Pitocin Par Health USA, LLC 2024-05-06
42023-0130-06 6 VIAL in 1 CARTON (42023-130-06) / 50 mL in 1 VIAL Pitocin Par Health USA, LLC 2018-05-01
63323-0012-07 25 VIAL in 1 TRAY (63323-012-07) / 1 mL in 1 VIAL (63323-01... Oxytocin Fresenius Kabi USA, LLC 2000-08-10
63323-0012-10 25 VIAL, MULTI-DOSE in 1 TRAY (63323-012-10) / 10 mL in 1 V... Oxytocin Fresenius Kabi USA, LLC 2000-08-10
63323-0012-11 25 VIAL in 1 TRAY (63323-012-11) / 1 mL in 1 VIAL (63323-01... Oxytocin Fresenius Kabi USA, LLC 2000-08-10
63323-0012-30 10 VIAL, MULTI-DOSE in 1 TRAY (63323-012-30) / 30 mL in 1 V... Oxytocin Fresenius Kabi USA, LLC 2000-08-10
Observed labelers: Par Health USA, LLC (6) · Fresenius Kabi USA, LLC (4) · West-Ward Pharmaceuticals Corp (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.